| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb32660cef3aefb637c76b1ebf81de26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d280a17bd8592252c23311c4d345e0af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfdd2da3ce642b39caf526cc0979fb20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51a0c49e5390c69aa92b87c3a892344c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4260a256b5f28ea7d92b4c1f5b921d0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-177
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2009-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7711a5be76a1aaeeef82c2370f3915b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfd8b21e5f67040e6232d01133488087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de75615e4ac12f8cdd8c62383dd6dfde |
| publicationDate |
2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010030840-A2 |
| titleOfInvention |
Novel receptor and uses thereof |
| abstract |
The invention provides agents that modulate the effect of a two pore calcium channel (TPC) polypeptide for use in the treatment or prophylaxis of a condition, disease or disorder associated with NAADP receptor-mediated biological activity. The invention also provides methods of identifying agents that modulate the effect of NAADP receptor mediated biological activity, and kits for use in such methods. Methods for the treatment or prophylaxis of a condition, disease or disorder associated with NAADP receptor- mediated biological activity are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016024246-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3527227-A4 |
| priorityDate |
2008-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |